Charmaine Smith
Olivia Newton-John Cancer Wellness & Research Centre(AU)Austin Health(AU)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Chronic Lymphocytic Leukemia Research, BRCA gene mutations in cancer
Most-Cited Works
- → Multiple newly identified loci associated with prostate cancer susceptibility(2008)849 cited
- → Anti-Müllerian hormone serum concentrations of women with germlineBRCA1orBRCA2mutations(2016)89 cited
- → Prostate cancer segregation analyses using 4390 families from UK and Australian population‐based studies(2009)33 cited
- → Identification of new genetic risk factors for prostate cancer(2008)24 cited
- → A whole of population‐based series of radical prostatectomy in Victoria, 1995 to 2000(2009)15 cited
- → Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study(2023)14 cited
- → Immune Priming with Single-Agent Nivolumab Followed By Combined Nivolumab & Rituximab Is Safe and Efficacious for First-Line Treatment of Follicular Lymphoma; Interim Analysis of the '1st FLOR' Study(2019)14 cited
- → Updated cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)(2006)13 cited
- → Safety and Efficacy of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of the Phase II Avr-CHOP Study(2020)10 cited
- → Anti-Müllerian Hormone Serum Concentrations of Women With Germline BRCA1 or BRCA2 Mutations(2016)10 cited